“The successful TGA approval for PromarkerD software as an IVD forms part of Proteomics...
PromarkerD secures TGA approval for software IVD and Indonesian patent
Proteomics International is pleased to announce TGA regulatory approval granted for PromarkerD software as an in vitro diagnostic (IVD) for export use, and the granting of a key PromarkerD patent in Indonesia.
The broadening of Proteomics International’s IP portfolio reflects the ambitions to execute licensing transactions globally, the granting of the Indonesian patent secures another potentially lucrative jurisdiction.